Severe hypertriglyceridemia appeared mainly during two-time points: After 4–6 weeks of therapy, or after 5–7 months of therapy, namely after the treatment phases in which asparaginase was administered and was not found to be associated with steroid type or with older age (Figure 4 and Figure S2). Here, ASPG is linked to hypertriglyceridemia.